Upgrade to SI Premium - Free Trial

iBio, Inc. (IBIO)

0.77 -0.01 (1.28%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/26)

Latest Headlines

Form 4 iBio, Inc. For: Oct 14 Filed by: Stoner Elizabeth October 15, 2026 6:34 PM - SEC Filing Form 4 iBio, Inc. For: Oct 14 Filed by: Kropotova Alexandra October 15, 2026 6:33 PM - SEC Filing Form 4 iBio, Inc. For: Oct 14 Filed by: Arkowitz David October 15, 2026 6:32 PM - SEC Filing Form 4 iBio, Inc. For: Oct 14 Filed by: Clark William D October 15, 2026 6:32 PM - SEC Filing Form 4 iBio, Inc. For: Oct 14 Filed by: Parada Antonio Bernardino Guimaraes October 15, 2026 6:31 PM - SEC Filing Form 4 iBio, Inc. For: Oct 14 Filed by: Sender Gary October 15, 2026 6:30 PM - SEC Filing Form SCHEDULE 13G iBio, Inc. Filed by: Coastlands Capital LP October 14, 2026 11:57 AM - SEC Filing Form 8-K iBio, Inc. For: Oct 13 October 13, 2026 8:25 AM - SEC Filing iBio reports IBIO-610 muscle-preservation data from primate study October 13, 2026 7:04 AM - StreetInsider iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy October 13, 2026 7:00 AM - StreetInsider H.C. Wainwright Starts iBio, Inc. (IBIO) at Buy September 17, 2026 6:07 AM - StreetInsider B.Riley Starts iBio, Inc. (IBIO) at Buy September 15, 2026 5:02 AM - StreetInsider Form 8-K iBio, Inc. For: Sep 14 September 14, 2026 4:17 PM - SEC Filing iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference September 1, 2026 4:30 PM - StreetInsider Form 10-K iBio, Inc. For: Jun 30 August 28, 2026 8:33 AM - SEC Filing Form 8-K iBio, Inc. For: Aug 28 August 28, 2026 8:31 AM - SEC Filing iBio posts $33M net loss in fiscal 2026 as R&D spending surges August 28, 2026 7:02 AM - StreetInsider iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update August 28, 2026 7:00 AM - StreetInsider Form PRE 14A iBio, Inc. For: Oct 14 August 20, 2026 6:59 AM - SEC Filing Form SCHEDULE 13G iBio, Inc. Filed by: Lynx1 Capital Management LP August 14, 2026 4:41 PM - SEC Filing Form SCHEDULE 13G/A iBio, Inc. Filed by: Vestal Point Capital, LP August 14, 2026 4:11 PM - SEC Filing Form SCHEDULE 13G/A iBio, Inc. Filed by: Cormorant Asset Management, LP August 14, 2026 2:04 PM - SEC Filing Form SCHEDULE 13G/A iBio, Inc. Filed by: Affinity Asset Advisors, LLC August 13, 2026 4:08 PM - SEC Filing Form 4 iBio, Inc. For: Jul 31 Filed by: Carr Molly August 4, 2026 4:02 PM - SEC Filing Form 3 iBio, Inc. For: Jul 31 Filed by: Carr Molly August 4, 2026 7:16 AM - SEC Filing Form 8-K iBio, Inc. For: Jul 31 August 4, 2026 7:06 AM - SEC Filing iBio names endocrinologist Molly Carr as chief medical officer August 4, 2026 7:00 AM - StreetInsider iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer August 4, 2026 7:00 AM - StreetInsider Full Article List